Wird geladen...

Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease

After 15 years of research into Alzheimer's disease (AD) therapeutics, including billions of US dollars provided by federal agencies, pharmaceutical companies, and private foundations, there are still no meaningful therapies that can delay the onset or slow the progression of AD. An understandi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Pharmacol
Hauptverfasser: Fitz, Nicholas F., Nam, Kyong Nyon, Koldamova, Radosveta, Lefterov, Iliya
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6715597/
https://ncbi.nlm.nih.gov/pubmed/30924124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14668
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!